This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Losardo, A. A. Articles by Frishman, W. H. Search for Related Content PubMed PubMed Citation Articles by Losardo, A. A. Articles by Frishman, W. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Beneficial Effects of Sublingual Nifedipine in Patients with Ischemic Heart Disease and Depressed Left Ventricular Function

Divisions of Cardiology, Departments of Medicine, The Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, Josè Gregorio Hernandez Hospital, Caracas, Venezuela

Neal A. Klein, M.D.

Nusen Beer, M.D.

Joel A. Strom, M.D.

John P. Wexler, M.D., Ph.D.

Edmund H. Sonnenblick, M.D.

William H. Frishman, M.D., F.A.C.A.

The effects of sublingual nifedipine, a calcium channel beta-blocking drug, were assessed in eleven patients with coronary artery disease and depressed left ventricular function. All patients had a previous documented myocardial infarction. Specifically examined were the effects of a 20 mg dose on left ventricular ejection fraction as assessed through gated pool nuclear imaging. All patients had their anti-anginal drugs stopped forty-eight hours prior to inclusion in the study. Baseline resting determinations included a mean heart rate of 80 beats/minute, mean arterial pressure of 97 mmHg and an ejection fraction of 36 percent. Thirty minutes following a 20 mg sublingual dose, these parameters were reassessed. Mean heart rate increased to 89 beats/minute, p<0.02; mean arterial pressure decreased to 78 mmHg, p<.002; while ejection fraction increased to 48± 17 percent, p<.001. No adverse reactions were reported. These results demonstrate that nifedipine will acutely improve de creased left ventricular function in patients with coronary artery disease. While calcium blockers can significantly depress myocardial contractility, nifedipine's ability to decrease mean arterial pressure and peripheral vascular resistance reduces afterload, improves myocardial performance which offsets any negative effects on contractility that may exist. This drug promises to be especially useful in patients with coronary artery disease and severely de pressed left ventricular function where agents such as beta-blockers are con traindicated.

Angiology, Vol. 33, No. 12, 811-817 (1982)
DOI: 10.1177/000331978203301207


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. M. MacMillan, Se Do Cha, and V. Maranhao Acute Hemodynamic Effects of Nifedipine During Supine Exercise in Patients with Prior Myocardial Infarction Angiology, March 1, 1986; 37(3): 168 - 174. [Abstract] [PDF]